Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cecilia Duan
Observed name:
Duan, Cecilia
OpenAlex ID:
A5111084214
Decision model to evaluate the cost of clinical events associated with switching from apixaban to rivaroxaban among patients with non-valvular atrial fibrillation in the United States and Germany
2025
·
Rupesh Subash
, Cecilia Duan
, et al.
·
Journal of Medical Economics
·
1
Number Needed to Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukaemia
2023
·
Asher Alban Chanan-Khan
, Kirollos S. Hanna
, et al.
·
Blood
·
1
PDF
Plain language summary examining clinical event related costs associated with changing medication from apixaban to rivaroxaban in people with non-valvular atrial fibrillation in the USA and Germany
2026
·
Rupesh Subash
, Cecilia Duan
, et al.
·
Journal of Medical Economics
PDF
Show more works
View as search
Works count:
4
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type